Clinical trial Recruiting at 1 site Interventional Ages 1 Year and up

Cholera control around a case area using targeted vaccination (CATI) in Dhaka

Official title: Case-area Targeted Interventions (CATIs) Among Household Contacts and Neighbouring Households After Defining Cholera Hotspot Areas in Bangladesh: The Effectiveness of OCV and Potential Impact on Cholera Control

Run by International Centre for Diarrhoeal Disease Research, Bangladesh · NCT07685574 · Data updated 2026-11-12

This study tests whether vaccinating household contacts around a cholera case in Dhaka can reduce transmission of the disease.

Quick facts

Study typeInterventional
Ages1 Year and up
SexAll
Enrollment68400 (estimated)
SponsorInternational Centre for Diarrhoeal Disease Research, Bangladesh
Academic / other
Locations1 site (Dhaka)
StatusRecruiting
StartedSeptember 5, 2024
Main results expectedSeptember 2029
Study endsDecember 31, 2029
Registry record updatedJuly 6, 2026
Trial IDNCT07685574 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are household contacts aged 1 year or older (non-pregnant) of a recent cholera case, who have not previously received the OCV.

Probably not a fit

Individuals who are currently pregnant, under 1 year of age, have received prior OCV, or are currently ill with diarrhea may not benefit from the vaccination strategy.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial targets households around newly diagnosed cholera cases identified at icddr,b. Within a 20–40 meter radius of an index case, eligible household contacts receive oral cholera vaccine (OCV) with one or two doses given one month apart, alongside ongoing passive surveillance for cholera. The study also explores bacterial genome analysis and immune responses to V. cholerae from hotspots. Data on infection states and transmission within clusters will be tracked to assess impact on cumulative cholera incidence. The approach aims to provide rapid, localized vaccination as a potentially effective outbreak response.

Why it matters

Potential benefit: If successful, this approach could shorten outbreaks and reduce cholera transmission in hotspot areas.

How similar studies have gone: Prior research suggests targeted vaccination around cholera cases is promising, but the effectiveness of rapid, hotspot-based vaccination needs confirmation in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Index case eligibility

Inclusion Criteria:

1. Some to severe dehydrated diarrheal patient
2. Provide signed informed consent form

Exclusion criteria:

1\. Resident in a ward already covered by OCV since 2015

Vaccination Eligibility

Inclusion Criteria:

1. Aged ≥1 year and non-pregnant
2. Meeting the definition of IHC and NHC
3. Provide signed informed consent form

Exclusion criteria:

1. History of taking OCV
2. Currently suffering from diarrhea
3. \< 1 year of age
4. Pregnant women (verbally confirmed)
5. Index case

Where it's running

  • International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b)
    Dhaka, Bangladesh
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.